Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

MBXMBX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MBX Biosciences, Inc.

GOLDMAN SACHS GROUP INC holds 459,005 shares of MBX (MBX Biosciences, Inc.), worth $25.3M as of 2026-Q2. The position was increased (+0.2% shares). MBX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$25.3M

Current Shares

459,005

Total Value Change

+$24.7M

Total Shares Change

+424,178

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
459,005
+0.2%
$25.3M0.0%$55.20
29
2026-Q1
Increased
457,945
+38.0%
$13.7M0.0%$30.54
37
2025-Q4
Decreased
331,938
-7.3%
$10.5M0.0%$30.90
0
2025-Q3
New
358,121
-
$6.3M0.0%$17.94
38
2025-Q2
Exited
0
-100.0%
$00.0%$10.75
0
2025-Q1
Decreased
15,168
-56.5%
$111,9400.0%$7.76
0
2024-Q4
New
34,827
-
$641,8620.0%$17.91
34

Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used